UK markets close in 8 hours 21 minutes

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4800+0.1400 (+10.45%)
At close: 04:00PM EDT
1.4800 0.00 (0.00%)
After hours: 07:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 186.12M
Enterprise value 102.16M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.17
Enterprise value/revenue N/A
Enterprise value/EBITDA 2.01

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 340.95%
S&P500 52-week change 321.83%
52-week high 32.3100
52-week low 30.6200
50-day moving average 31.3138
200-day moving average 31.1061

Share statistics

Avg vol (3-month) 31.34M
Avg vol (10-day) 31.03M
Shares outstanding 5125.76M
Implied shares outstanding 6125.76M
Float 8117.92M
% held by insiders 10.06%
% held by institutions 121.77%
Shares short (28 Jun 2024) 410.28M
Short ratio (28 Jun 2024) 46.3
Short % of float (28 Jun 2024) 48.18%
Short % of shares outstanding (28 Jun 2024) 48.18%
Shares short (prior month 31 May 2024) 411.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 320 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-18.85%
Return on equity (ttm)-29.84%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -31.23M
Net income avi to common (ttm)-29.69M
Diluted EPS (ttm)-0.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)83.96M
Total cash per share (mrq)0.67
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)16.34
Book value per share (mrq)0.68

Cash flow statement

Operating cash flow (ttm)-18.62M
Levered free cash flow (ttm)-9.78M